Seres Therapeutics jumped 21% in premarket trading after a report that Nestle made a takeover offer of ~$760 million for the company.
The $41 a share all-cash offer was valid until the end of August, according to Swiss blog Inside Paradeplatz, which cited a Nestle letter dated Aug. 14. The offer also includes milestone payments.
Seres Therapeutics has a market cap of $169 million.
The report comes after Seres (NASDAQ:MCRB) last year announced that Nestlé Health Science, a unit of consumer care giant Nestlé (OTCPK:NSRGY), agreed to purchase its oral microbiome therapy Vowst for $175 million.
There was also a Betaville report last September that Nestle made a takeover offer for Seres (NASDAQ:MCRB) that was rebuffed.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.